Novel assessment of a novel meningitis B vaccine

The Lancet Infectious Diseases

Volumn 13, Issue 5, 2013, Pages 381-382

  Gill, Christopher J ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGITIS VACCINE;

DRUG POTENCY; LETTER; MENINGITIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; VACCINATION;

GENES, BACTERIAL; HUMANS; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP B;

EID: 84876744244     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70037-9     Document Type: Letter

References (11)

1. Pollard AJ Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J 2004, 23(12 suppl):S274-S279.
2. Harrison LH, Trotter CL, Ramsay ME Global epidemiology of meningococcal disease. Vaccine 2009, 27(suppl 2):B51-B63.
3. Finne J, Bitter-Suermann D, Goridis C, Finne U An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol 1987, 138:4402-4407.
4. Pizza M, Scarlato V, Masignani V, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000, 287:1816-1820.
5. Martin DR, Walker SJ, Baker MG, Lennon DR New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4. J Infect Dis 1998, 177:497-500.
6. Bexsero: opinion European Medicines Agency, (accessed Jan 29, 2013). http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002333/smops/Positive/human_smop_000447.jsp&mid=WC0b01ac058001d127.
7. Ulrich Vogel, Muhamed-Kheir Taha, Julio A Vazquez, et al. Predicted strain coverage of a meningococcal multicomponent vaccine in Europe: a qualitative and quantitative assessment. Lancet Infect Dis 2013, published online Feb 13. http://dx.doi.org/10.1016.S1473-3099(13)70006-9.
8. Goldschneider I, Gotschlich EC, Artenstein MS Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969, 129:1307-1326.
9. Brueggemann AB, Pai R, Crook DW, Beall B Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 2007, 3:e168.
10. Granoff DM Review of meningococcal group B vaccines. Clinical Infect Dis 2010, 50(suppl 2):S54-S65.
11. Boisier P, Nicolas P, Djibo S, et al. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clinical Infect Dis 2007, 44:657-663.